Who Just Raised
Get Pro

Rockville, MD · Health Care · Form D filed Oct 14, 2026No press found

Kaigene, Inc. raised $55M

Kaigene, Inc. is a biotechnology company based in Rockville, Maryland. In a Form D filed with the SEC on October 14, 2026, it reported raising $54,958,229 from 22 investors as part of an offering of up to $73,350,000. The first sale in the offering took place on September 30, 2026.

No press found. No news article or press release about this raise turned up when we searched on October 15, 2026. Announcements sometimes come weeks after a filing, so we check again. More raises with no press found

$56.3M raised since 2020

2 Form D offerings, as reported to the SEC, the first in Mar 29, 2022. Amendments update a round; they aren't counted twice.

FiledSoldOffering sizeInvestors
Oct 14, 2026$55M$73.3M22
Mar 29, 2022$1.4M$5M3

Lead score

64 out of 100

filed this week early raise still raising budget to spend no press yet

Outreach kit How it works 1:21

A first message that shows you did your homework, written from this filing. Fill in the brackets and send.

Email · subject: Congrats on the new round

Hi [first name],

Congrats on the new round. I saw the raise in your SEC filing.

Teams at this stage usually start looking at [what you do] right after a round...

[Your name]

LinkedIn note

Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?

Call opener

Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...

Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing

Track this company How it works 0:56

Saved to your dashboard pipeline, with a badge in Explore.

Loading your outreach kit…

The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.

Start your free trial Already on Pro? Sign in

Filing details

Amount raised
$54,958,229
Offering size
$73,350,000
Investors so far
22
First sale
September 30, 2026
Securities offered
Equity
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Rockville, Maryland
Incorporated
Delaware, 2021
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $54,958,229 $73,350,000 22 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Updated · Raises in the week of Oct 12, 2026 · Health Care funding in Maryland

Health CareNo press found $7M

Templar Nova, Inc.

Rockville, MD · filed Oct 7

First Form D

Health Care $975K

ColoWatch, Inc.

Gaithersburg, MD · filed Oct 8

Virtual colonoscopy screening with no sedation, standardized protocols, secure cloud delivery, advanced 3D visualization, and expert radiologist interpretation.

First Form DStill raising

Health Care $10M

Seraxis Holdings, Inc.

Germantown, MD · filed Sep 24

Seraxis is a private biotechnology company that has developed a novel cell and immune-evasion technology with the goal to reverse Type 1 Diabetes.

2nd Form D since 2021

Health Care $75K

Aromha, Inc.

Potomac, MD · filed Sep 24

3rd Form D since 2025

Who Just Raised Pro

The raises that matter to you, in your inbox every weekday morning.

Your sectors, states and deal size · first-time vs repeat raisers · open rounds · a watchlist · every raise as a spreadsheet each Monday.